SCHEMBL20095281

SCHEMBL20095281

Cc1ccc2sc3cc(-c4cc5oc6ccccc6c5cc4C)ccc3c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.39
MAOA P21397 1/20 0.39
CYP1A2 P05177 1/20 0.36
TNKS O95271 1/20 0.36
PARP1 P09874 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
AHR P35869 3/20 0.35
MAPT P10636 7/20 0.35
HPGD P15428 6/20 0.35
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
PGR P06401 1/20 0.34
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 3/20 0.33
TP53 P04637 2/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21109951 0.83 MAOB (0.47) MAOBMAOACYP1A2TNKSPARP1
SCHEMBL21109946 0.82 MAPT (0.43) TNKSTNKS2MAPTHPGDALDH1A1
SCHEMBL26529714 0.79 ALDH1A1 (0.47) CYP1A2MAPTHPGDALDH1A1KDM4E
SCHEMBL19292713 0.78 MAOB (0.40) MAOBMAOACYP1A2TNKSPARP1
SCHEMBL20987510 0.77 ALOX5 (0.54) MAOBMAOATNKSPARP1TNKS2
SCHEMBL19110126 0.76 MAPT (0.35) CYP1A2AHRMAPTHPGDALDH1A1
SCHEMBL18597136 0.76 MAPT (0.47) MAOAAHRMAPTHPGDALDH1A1
SCHEMBL23426917 0.76 MAPT (0.41) MAOACYP1A2AHRMAPTHPGD
SCHEMBL23426915 0.76 AHR (0.41) MAOBMAOAAHRMAPTHPGD
SCHEMBL19743192 0.76 PDE10A (0.38) MAOBMAOACYP1A2AHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180114922-A1 COMPOUND AND PREPARATION METHOD THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO. LTD. (CN) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114922-A1 COMPOUND AND PREPARATION METHOD THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE LEF1, TYR, LSS MAOB 39/4885MAOA 74/4885CYP1A2 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.